dyscrasia


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

dys·cra·sia

 (dĭs-krā′zhə, -zhē-ə)
n.
An abnormal bodily condition, especially of the blood.

[Medieval Latin, bad mixture, disease, from Greek duskrāsiā : dus-, dys- + krāsis, mixing; see kerə- in Indo-European roots.]

dyscrasia

(dɪsˈkreɪzɪə)
n
(Physiology) obsolete any abnormal physiological condition, esp of the blood
[C19: New Latin, from Medieval Latin: an imbalance of humours, from Greek, from dys- + -krasia, from krasis a mixing]

dys•cra•sia

(dɪsˈkreɪ ʒə, -ʒi ə, -zi ə)

n.
an imbalance of the constituents of the blood or bone marrow.
[1350–1400; Middle English < Medieval Latin < Greek dyskrasía bad mixture =dys- dys- + krâs(is) a mixing + -ia -ia]
dys•cra′sial, dys•cras′ic (-ˈkræz ɪk, -ˈkræs-) dys•crat′ic, adj.

dyscrasia

Medicine. an unhealthy condition, especially an imbalance of physiologic or constitutional elements, often of the blood. Cf. eucrasia.dyscrasic, dyscratic, adj.
See also: Health
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.dyscrasia - an abnormal or physiologically unbalanced state of the body
health problem, ill health, unhealthiness - a state in which you are unable to function normally and without pain
blood dyscrasia - any abnormal condition of the blood
Translations

dyscrasia

n discrasia
References in periodicals archive ?
Overall, PSRs resulted in a WHO diagnosis in 80 of 85 cases (94%) compared with 54 (64%) for the hematopathology report alone, with increases observed in the cytopenia, MPN, plasma cell dyscrasia, and lymphoma tracks.
Light-chain-mediated acute tubular interstitial nephritis: a poorly recognized pattern of renal disease in patients with plasma cell dyscrasia. Arch Pathoi Lab Med 2006; 130: 165-169.
If associated with monoclonal plasma cell dyscrasia, it is categorized as primary, and when it occurs as a complication of chronic inflammatory diseases, including rheumatoid arthritis, chronic osteomyelitis, or malignancies, it is categorized as secondary.
The exclusion criteria for this study were: refusal to receive blood products for any reason, a history of blood dyscrasia or other clotting abnormality, anterior only surgical approach, or current use of an anticoagulant.
An SPE is appropriate, however, in an older patient with unexplained anemia, known low immunoglobulin levels, unexplained renal insufficiency or neuropathy, or osteopenia or osteoporosis inconsistent with the patient's age or gender--provided the patient doesn't have a coexisting plasma cell dyscrasia or B-cell lymphoproliferative disorder, which would throw off the prognostic value of the test results, he continued.
Primary systemic amyloidosis (AL amyloidosis), which is usually associated with an underlying plasma cell dyscrasia, involves the deposition of insoluble monoclonal immunoglobulin light chains in the skin, muscles, connective tissues, blood vessel walls, peripheral nerves, heart, kidneys, gastro-intestinal tract, and lungs (2).
"Epidermotropism refers to a state of abnormal colonization of the epidermis by leukocytes, which often reflects a clonal T-cell or monocyte dyscrasia. Epidermotropism is a distinctive pattern of passive migration into epithelial structures that is not otherwise attributable to the normal function of innate and adaptive immunity," the researchers explained.
Her medical history was significant for extranodal marginal zone lymphoma, plasma cell dyscrasia and amyloidosis diagnosed one year earlier following biopsy of a right cheek mass.
Also excluded were patients conforming to physical status classification IV (American Society of Anesthesiologists), those with a history of nasal fracture or previous nasal surgery, those with a history of sinusitis or nasal tumor, and those with underlying blood dyscrasia.
Thus, myocardial scintigraphy can diagnose cardiac ATTR amyloidosis without histological confirmation as long as there is no plasma cell dyscrasia [15, 17].
However, the prevalence of the commonest inherited blood dyscrasia among Asians, beta-thalassemia, has been evaluated among large populations in both China and India with similar prevalence of beta-thalassaemia status of around 3% [33, 34].